Institutional members access full text with Ovid®

Share this article on:

Minimally Invasive Myomectomy

FLYCKT, REBECCA MD; COYNE, KATHRYN BS; FALCONE, TOMMASO MD

Clinical Obstetrics and Gynecology: June 2017 - Volume 60 - Issue 2 - p 252–272
doi: 10.1097/GRF.0000000000000275
New Developments in Minimally Invasive Surgery

Uterine fibroids can significantly impact a woman’s health, fertility, and quality of life. When medical therapy fails, surgery is recommended; the gold standard in uterine-sparing surgery is myomectomy. The evidence-based benefits of minimally invasive myomectomy are detailed in this manuscript. Minimally invasive myomectomy techniques are reviewed, including laparoscopic, robotic-assisted, and laparoscopic or robotic-assisted with mini-laparotomy. Criteria for minimally invasive myomectomy are outlined and preoperative planning is discussed. Both institutional data and data from systematic reviews are included to compare outcomes. Each myomectomy case should take into account clinical characteristics of the myomas, patient preference, and surgeon skill and experience.

Obstetrics, Gynecology, and Women’s Health Institute, Section of Reproductive Endocrinology and Infertility, Cleveland Clinic, Cleveland, Ohio

The authors declare that they have nothing to disclose.

Correspondence: Tommaso Falcone, MD, Obstetrics, Gynecology, and Women’s Health Institute, Section of Reproductive Endocrinology and Infertility, Cleveland Clinic, Cleveland, OH. E-mail: falcont@ccf.org

Copyright © 2017 Wolters Kluwer Health, Inc. All rights reserved.